Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases (Q43735034)

26 November 2017

Plasma endoglin as a marker to predict cardiovascular events in patients with chronic coronary artery diseases (English)

1 reference

26 November 2017

1 reference

Tomokazu Ikemoto

1

1 reference

26 November 2017

Yukihiro Hojo

2

1 reference

26 November 2017

Hideyuki Kondo

3

1 reference

26 November 2017

Nozomu Takahashi

4

1 reference

26 November 2017

Masahiro Hirose

5

1 reference

26 November 2017

Yoshioki Nishimura

6

1 reference

26 November 2017

Takaaki Katsuki

7

1 reference

26 November 2017

Kazuyuki Shimada

8

1 reference

26 November 2017

Kazuomi Kario

9

1 reference

26 November 2017

11 June 2011

1 reference

26 November 2017

1 reference

26 November 2017

27

1 reference

26 November 2017

4

1 reference

26 November 2017

344-351

1 reference

https://scigraph.springernature.com/pub.10.1007/s00380-011-0163-z

26 November 2017

0 references

cites work

Endoglin (CD105): a marker of tumor vasculature and potential target for therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Hereditary haemorrhagic telangiectasia: a clinical and scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. A comparison of cineangiographic and radionuclide techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Revised equations for estimated GFR from serum creatinine in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Inducible expression of human endoglin during inflammation and wound healing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

S-endoglin expression is induced in senescent endothelial cells and contributes to vascular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00380-011-0163-Z

Serum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressure

21 January 2018

1 reference

12 December 2020

Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration

1 reference

12 December 2020

Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum

1 reference

12 December 2020

Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques

1 reference

12 December 2020

The significance of CD105, TGFbeta and CD105/TGFbeta complexes in coronary artery disease

1 reference

12 December 2020

Significant expression of endoglin (CD105), TGFbeta-1 and TGFbeta R-2 in the atherosclerotic aorta: an immunohistological study

1 reference

12 December 2020

10.1007/S00380-011-0163-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

0 references

1 reference